MorphoSys AG
MPSYF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $1 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | $2 | $0 | $1 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -14.4% | 54.9% | -45.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 75.5% | 82.5% | 82.1% | 97.2% |
| EBITDA | -$0 | $0 | -$0 | $0 |
| % Margin | -41% | 62.1% | -184.4% | 39% |
| Net Income | -$0 | -$0 | -$1 | $0 |
| % Margin | -79.6% | -54.3% | -286.5% | 29.9% |
| EPS Diluted | -5.53 | -4.42 | -15.4 | 2.97 |
| % Growth | -25.1% | 71.3% | -618.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$1 | -$0 |